Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
DMK Pharmaceuticals (GB:0A4X)
LSE:0A4X
DMK Pharmaceuticals (0A4X) Financial Statements
0 Followers
DMK Pharmaceuticals Financial Overview
| Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 9.06K | $ 6.95K | $ 1.45M | $ 2.06M | $ 1.51M |
| Gross Profit | $ -329.43K | $ -354.45K | $ -335.07K | $ -331.11K | $ -141.90K |
| EBIT | $ -1.71M | $ -6.96M | $ -9.01M | $ -3.94M | $ -4.27M |
| EBITDA | $ -1.64M | $ -6.87M | $ -8.91M | $ -3.57M | $ -3.87M |
| Net Income Common Stockholders | $ -1.74M | $ -8.57M | $ 6.82M | $ -3.33M | $ -4.40M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 6.66M | $ 670.34K | $ 3.13M | $ 1.11M | $ 2.42M |
| Total Assets | $ 8.96M | $ 4.75M | $ 9.08M | $ 10.93M | $ 12.14M |
| Total Debt | $ 63.21K | $ 157.25K | $ 250.36K | $ 342.56K | $ 432.02K |
| Net Debt | $ -6.60M | $ -513.10K | $ -2.88M | $ -768.87K | $ -1.99M |
| Total Liabilities | $ 13.92M | $ 16.57M | $ 18.60M | $ 11.58M | $ 9.29M |
| Stockholders Equity | $ -5.29M | $ -11.83M | $ -9.68M | $ -808.07K | $ 2.85M |
| Cash Flow | - | ||||
| Free Cash Flow | $ 2.80M | $ -2.57M | $ -1.54M | $ 2.43M | $ -7.71M |
| Operating Cash Flow | $ 2.80M | $ -2.57M | $ -1.55M | $ -1.57M | $ -7.50M |
| Investing Cash Flow | $ 1.77M | $ 138.29K | $ 841.78K | $ 81.86K | $ 779.22K |
| Financing Cash Flow | $ 1.42M | $ 750.00 | $ 2.72M | - | $ 285.00K |
DMK Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.